Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Are The Future Growth Projections For The Angina Market Size?

The market for angina has witnessed a robust growth in the past couple of years. It is anticipated to scale from $10.71 billion in 2024 to $11.36 billion in 2025, with an annual growth rate of 6.1%. This considerable growth during the historical phase can be attributed to various factors such as a rise in instances of coronary heart disease, more frequent use of vasodilators, growing cases of myocardial ischemia, advancements in diagnostic abilities, and heightened utilization of imaging technologies.

Expectations are high for a robust expansion in the angina market in the upcoming years. The market is predicted to increase to a value of $14.18 billion by 2029, experiencing a compounding annual growth rate of 5.7%. This projected growth during the said period can be linked to several factors. Factors such as the escalating occurrence of chronic angina pectoris, an uptick in drug approvals and clinical studies, a surge in demand for retail pharmacies, growing consciousness regarding cardiovascular health and a rising demand for medications. Important trends that will shape the forecast period include, breakthroughs in technology for early diagnosis, advancements in angioplasty and stenting, new strategies in gene therapy, growing need for coronary stents, and progress in coronary artery disease treatment measures.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Which Factors Are Steering Growth In The Angina Market?

The increasing instances of coronary artery diseases are projected to stimulate the angina market’s expansion in the future. Coronary artery disease (CAD), alternatively referred to as coronary heart disease (CHD) or ischemic heart disease (IHD), is typified by the constriction or blockage of the coronary arteries that deliver blood, oxygen, and essential nutrients to the heart muscle. The mounting cases of CAD can be attributed to modifications in lifestyle as well as genetic and environmental factors. Angina has a significant role in recognizing and comprehending the prevalence of CAD. Its detection encourages clinical assessment, diagnosis, risk stratification, guideline treatment choices, and public health strategies formulation. For instance, the American Heart Association reported that the number of adults dealing with CAD in the U.S. escalated from 18.2 million to an estimated 19.3 million between 2021 and 2022. Consequently, the escalating cases of CAD fuel the growth of the angina market.

How Is The Angina Market Organized By Different Segments?

The anginamarket covered in this report is segmented –

1) By Type: Angina Pectoris; Unstable Angina; Prinzmetal Angina; Other Types

2) By Treatment: Lifestyle Changes; Medications; Angioplasty And Stenting; Coronary Bypass Surgery; Other Treatments

3) By Drug Class: Beta Blockers; Nitrates And Calcium Channel Blockers; Angiotensin-Converting Enzyme Inhibitors; Other Drug Classes

4) By Application: Clinics; Hospitals; Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina; Chronic Stable Angina; Effort-Induced Angina; Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina; Pre-Infarction Angina; Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina; Coronary Artery Spasm-Induced Angina; Variant Angina

4) By Other Types: Nocturnal Angina; Post-Infarction Angina; Angina With Silent Myocardial Ischemia; Angina Due To Aortic Stenosis Or Valve Disease

What Current And Upcoming Trends Are Shaping The Angina Market?

Leading firms in the angina market are working on the creation of innovative medications like metoprolol tartrate tablets, intended for more precise and efficient treatments for patients diagnosed with coronary artery disease (CAD) and associated conditions. Metoprolol tartrate tablets are often used to manage different cardiovascular diseases, such as angina (chest pain), hypertension (high blood pressure), and heart failure. For example, Zydus, a pharmaceutical company based in India, earned the final approval in April 2023 from the US Food and Drug Administration (US-FDA) to produce and sell their own generic version of Metoprolol Tartrate Tablets USP, in dosages of 25 mg, 50 mg, and 100 mg. Metoprolol, a beta blocker, is typically used to address several cardiovascular issues like hypertension (high blood pressure) and angina (chest pain), as well as increasing survival rates post a heart attack.

Who Are The Most Influential Companies In The Angina Market?

Major companies operating in the angina market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche AG, Merck & Co Inc., Bayer AG, Sanofi S.A., Novartis AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott laboratories, GlaxoSmithKline Plc, Eli Lilly and Company, Gilead Sciences Inc., Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co. Ltd., Troikaa Pharmaceuticals Ltd, Amgen Inc., Dr. Reddy’s Laboratories, ViroMed Co. Ltd., Lee’s Pharmaceutical Holdings, Kuhnil Pharmaceutical, LegoChem Biosciences, Axus Cardium Pharmaceuticals, Juventas Therapeutics, Milestone Pharmaceuticals

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Which Region Dominates The Angina Market Today?

North America was the largest region in the angina market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=16337&type=smp

Browse Through More Reports Similar to the Global Angina Market 2025, By The Business Research Company

Medical Software Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medical-software-global-market-report

Generative Ai In Healthcare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generative-ai-in-healthcare-global-market-report

Clinical Nutrition For Diabetes Care Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-nutrition-for-diabetes-care-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model